The LSC17 Score Correlates with the ELN 2022 Classification of AML and Is an Independent Predictor of Detectable Measurable Residual Disease after Induction Chemotherapy
Autor: | Murphy, Tracy, Ng, Stanley W.K. *, King, Ian *, Zhang, Tong *, Arruda, Andrea *, Claudio, Jaime *, Pan, Kristele *, Rockwell, Chantal *, Lu, Zhibin *, Stickle, Natalie *, Virtanen, Carl *, Gupta, Vikas, Maze, Dawn, McNamara, Caroline *, Schimmer, Aaron D., Schuh, Andre C., Sibai, Hassan *, Yee, Karen, Khalaf, Dina *, Leber, Brian, Sabloff, Mitchell, Tierens, Anne, Minden, Mark D., Stockley, Tracy L. *, Chan, Steven *, Wang, Jean C.Y. |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:9122-9124 |
Databáze: | ScienceDirect |
Externí odkaz: |